umarjan11/Medical-qna huggingface dataset:
Question: What causes Psoriasis ?

Answer: Although the cause of psoriasis is not completely understood, scientists believe it is related to a problem with a type of blood cells called T cells. These cells normally travel through the bloodstream to help fight an infection, but in people with psoriasis, they attack the bodys skin cells by mistake.
Question: What causes Hairy tongue ?

Answer: What causes hairy tongue? The exact cause is unknown; however, smoking, alcohol, dehydration, use of antibiotics, low saliva production, trigeminal neuralgia, poor oral hygiene and cranial radiation therapy have shown to bring about hairy tongue.
Question: What causes Lymphomatoid papulosis ?

Answer: What causes lymphomatoid papulosis? The cause of lymphomatoid papulosis is unknown, but it is associated with a proliferation of atypical T-cells. T-cells are specific white blood cells involved in immune responses.
Question: Is Acute intermittent porphyria inherited ?

Answer: How is acute intermittent porphyria (AIP) inherited? AIP is inherited in an autosomal dominant fashion, which means only one of the two HMBS genes needs to have a disease-causing mutation to decrease enzyme activity and cause symptoms.
Question: What are the treatments for Familial exudative vitreoretinopathy ?

Answer: How might familial exudative vitreoretinopathy be treated? Affected individuals with abnormal blood vessel formation in their retina can be treated with laser therapy. Surgery may also be necessary to correct retinal detachment.
Question: What are the treatments for Benign rolandic epilepsy (BRE) ?

Answer: What treatment is available for benign rolandic epilepsy? Although treatment is usually not necessary since the episodes are infrequent and are typically outgrown by puberty, anticonvulsants such as carbamazepine.
Question: What causes Cerebrotendinous xanthomatosis ?

Answer: What causes cerebrotendinous xanthomatosis? Cerebrotendinous xanthomatosis is caused by mutations in the CYP27A1 gene. This condition is inherited in an autosomal recessive pattern.
Question: what research (or clinical trials) is being done for Myotonia ?

Answer: The National Institute of Neurological Disorders and Stroke supports and conducts an extensive research program on neuromuscular disorders. The goals of this research are to learn more about these disorders and to find ways to treat, prevent, and cure them.
Question: what research (or clinical trials) is being done for Cerebral Hypoxia ?

Answer: The NINDS supports and conducts studies aimed at understanding neurological conditions that can damage the brain, such as cerebral hypoxia. The goals of these studies are to find ways to prevent and treat these conditions.
Question: What are the treatments for Septo-Optic Dysplasia ?

Answer: Treatment for SOD is symptomatic. Hormone deficiencies may be treated with hormone replacement therapy. The optical problems associated with SOD are generally not treatable. Vision, physical, and occupational therapies may be required.
Question: What are the treatments for Dysgraphia ?

Answer: Treatment for dysgraphia varies and may include treatment for motor disorders to help control writing movements. Other treatments may address impaired memory or other neurological problems. Some physicians recommend that individuals with dysgraphia use computers to avoid the problems of handwriting.
Question: what research (or clinical trials) is being done for Neurosyphilis ?

Answer: The National Institute of Neurological Disorders and Stroke supports and conducts research on neurodegenerative disorders, such as neurosyphilis, in an effort to find ways to prevent, treat, and ultimately cure these disorders.
Question: what research (or clinical trials) is being done for Benign Essential Blepharospasm ?

Answer: The NINDS supports a broad program of research on disorders of the nervous system, including BEB. Much of this research is aimed at increasing understanding of these disorders and finding ways to prevent, treat, and cure them.
Question: What are the treatments for Hereditary Spastic Paraplegia ?

Answer: There are no specific treatments to prevent, slow, or reverse HSP. Symptomatic treatments used for spasticity, such as muscle relaxants, are sometimes helpful. Regular physical therapy is important for muscle strength and to preserve range of motion.
Question: How many people are affected by dilated cardiomyopathy with ataxia syndrome ?

Answer: DCMA syndrome is a very rare disorder. Approximately 30 cases have been identified in the Dariusleut Hutterite population of the Great Plains region of Canada. Only a few affected individuals have been identified outside this population.
Question: How many people are affected by Koolen-de Vries syndrome ?

Answer: The prevalence of Koolen-de Vries syndrome is estimated to be 1 in 16,000. However, the underlying genetic cause is often not identified in people with intellectual disability, so this condition is likely underdiagnosed.
Question: How many people are affected by 1p36 deletion syndrome ?

Answer: 1p36 deletion syndrome is believed to affect between 1 in 5,000 and 1 in 10,000 newborns. However, this may be an underestimate because some affected individuals are likely never diagnosed.
Question: Is critical congenital heart disease inherited ?

Answer: Most cases of CCHD are sporadic, which means they occur in people with no history of the disorder in their family. However, close relatives (such as siblings) of people with CCHD may have an increased risk of being born with a heart defect compared with people in the general population.
Question: How many people are affected by familial idiopathic basal ganglia calcification ?

Answer: FIBGC is thought to be a rare disorder; about 60 affected families have been described in the medical literature. However, because brain imaging tests are needed to recognize the calcium deposits, this condition is believed to be underdiagnosed.
Question: Is retroperitoneal fibrosis inherited ?

Answer: Most cases of retroperitoneal fibrosis are sporadic, which means that they occur in people with no apparent history of the disorder in their family. In rare cases, the condition has been reported to occur in a few members of the same family, but the inheritance pattern is unknown.
Question: Is myasthenia gravis inherited ?

Answer: In most cases, myasthenia gravis is not inherited and occurs in people with no history of the disorder in their family. About 3 to 5 percent of affected individuals have other family members with myasthenia gravis or other autoimmune disorders, but the inheritance pattern is unknown.
Question: How many people are affected by retinitis pigmentosa ?

Answer: Retinitis pigmentosa is one of the most common inherited diseases of the retina (retinopathies). It is estimated to affect 1 in 3,500 to 1 in 4,000 people in the United States and Europe.
Question: What is (are) Financial Help for Diabetes Care ?

Answer: People who enroll in Medicare can register with www.MyMedicare.gov, a secure online service, and use the site to access their personal Medicare information at any time. People can view their claims and order history, and see a description of covered preventive services.
Question: What is (are) What I need to know about Hepatitis C ?

Answer: Acute hepatitis C is a short-term infection with the hepatitis C virus. Symptoms can last up to 6 months. The infection sometimes clears up because your body is able to fight off the infection and get rid of the virus.
Question: What are the treatments for Dry Mouth ?

Answer: Certain cancer treatments can affect the salivary glands. Head and neck radiation therapy can cause the glands to produce little or no saliva. Chemotherapy may cause the salivary glands to produce thicker saliva, which makes the mouth feel dry and sticky.
Question: What is (are) Dry Mouth ?

Answer: National Institute of Dental and Craniofacial Research  1 NOHIC Way  Bethesda, MD 20892-3500  (301) 402-7364  http://www.nidcr.nih.gov
Question: Do you have information about Native American Health

Answer: Summary : Every racial or ethnic group has specific health concerns. Differences in the health of groups can result from:       - Genetics    - Environmental factors    - Access to care    - Cultural factors        On this page, you'll find links to health issues that affect Native Americans.
Question: What is the outlook for Arachnoid Cysts ?

Answer: Untreated, arachnoid cysts may cause permanent severe neurological damage when progressive expansion of the cyst(s) or bleeding into the cyst injures the brain or spinal cord. Symptoms usually resolve or improve with treatment.
Question: What are the treatments for Angelman Syndrome ?

Answer: There is no specific therapy for Angelman syndrome. Medical therapy for seizures is usually necessary. Physical and occupational therapies, communication therapy, and behavioral therapies are important in allowing individuals with Angelman syndrome to reach their maximum developmental potential.
Question: What is the outlook for Barth Syndrome ?

Answer: Early and accurate diagnosis is key to prolonged survival for boys born with Barth syndrome. The disorder was once considered uniformly fatal in infancy, but some individuals are now living much longer. Severe infections and cardiac failure are common causes of death in affected children.
Question: what research (or clinical trials) is being done for Schizencephaly ?

Answer: The NINDS conducts and supports a wide range of studies that explore the mechanisms of normal brain development. The knowledge gained from these fundamental studies provides the foundation for understanding how to prevent or treat developmental brain defects such as schizencephaly.
Question: what research (or clinical trials) is being done for Moebius Syndrome ?

Answer: The NINDS conducts and supports a broad range of research on neurogenetic disorders, including Moebius syndrome. The goals of these studies are to develop improved techniques to diagnose, treat, and eventually cure these disorders.
Question: what research (or clinical trials) is being done for Hydrocephalus ?

Answer: The NINDS conducts and supports a wide range of fundamental studies that explore the complex mechanisms of normal brain development. Much of this research focuses on finding better ways to protect, treat, and ultimately cure disorders such as hydrocephalus.
Question: What are the treatments for Frontotemporal Dementia ?

Answer: No treatment has been shown to slow the progression of FTD. Behavior modification may help control unacceptable or dangerous behaviors. Aggressive, agitated, or dangerous behaviors could require medication. Anti-depressants have been shown to improve some symptoms.
Question: What is the outlook for Trigeminal Neuralgia ?

Answer: The disorder is characterized by recurrences and remissions, and successive recurrences may incapacitate the patient. Due to the intensity of the pain, even the fear of an impending attack may prevent activity. Trigeminal neuralgia is not fatal.
Question: What is (are) essential pentosuria ?

Answer: Essential pentosuria is a condition characterized by high levels of a sugar called L-xylulose in urine. The condition is so named because L-xylulose is a type of sugar called a pentose. Despite the excess sugar, affected individuals have no associated health problems.
Question: How many people are affected by propionic acidemia ?

Answer: Propionic acidemia affects about 1 in 100,000 people in the United States. The condition appears to be more common in several populations worldwide, including the Inuit population of Greenland, some Amish communities, and Saudi Arabians.
Question: How many people are affected by nonsyndromic holoprosencephaly ?

Answer: Nonsyndromic holoprosencephaly accounts for approximately 25 to 50 percent of all cases of holoprosencephaly, which affects an estimated 1 in 10,000 newborns.
Question: How many people are affected by lactate dehydrogenase deficiency ?

Answer: Lactate dehydrogenase deficiency is a rare disorder. In Japan, this condition affects 1 in 1 million individuals; the prevalence of lactate dehydrogenase deficiency in other countries is unknown.
Question: How many people are affected by hereditary angioedema ?

Answer: Hereditary angioedema is estimated to affect 1 in 50,000 people. Type I is the most common, accounting for 85 percent of cases. Type II occurs in 15 percent of cases, and type III is very rare.
Question: Is Li-Fraumeni syndrome inherited ?

Answer: Li-Fraumeni syndrome is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to increase the risk of developing cancer. In most cases, an affected person has a parent and other family members with cancers characteristic of the condition.
Question: How many people are affected by megalencephaly-capillary malformation syndrome ?

Answer: The prevalence of MCAP is unknown. At least 150 affected individuals have been reported in the medical literature. Because the condition is often thought to be misdiagnosed or underdiagnosed, it may be more common than reported.
Question: Is distal hereditary motor neuropathy, type V inherited ?

Answer: This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.  Some people who have the altered gene never develop the condition, a situation known as reduced penetrance.
Question: How many people are affected by Tourette syndrome ?

Answer: Although the exact incidence of Tourette syndrome is uncertain, it is estimated to affect 1 to 10 in 1,000 children. This disorder occurs in populations and ethnic groups worldwide, and it is more common in males than in females.
Question: How many people are affected by multiple mitochondrial dysfunctions syndrome ?

Answer: Multiple mitochondrial dysfunctions syndrome is a rare condition; its prevalence is unknown. It is one of several conditions classified as mitochondrial disorders, which affect an estimated 1 in 5,000 people worldwide.
Question: How many people are affected by juvenile myoclonic epilepsy ?

Answer: Juvenile myoclonic epilepsy affects an estimated 1 in 1,000 people worldwide. Approximately 5 percent of people with epilepsy have juvenile myoclonic epilepsy.
Question: How many people are affected by guanidinoacetate methyltransferase deficiency ?

Answer: Guanidinoacetate methyltransferase deficiency is a very rare disorder. About 80 affected individuals have been described in the medical literature. Of these, approximately one-third are of Portuguese origin.
Question: How many people are affected by primary hyperoxaluria ?

Answer: Primary hyperoxaluria is estimated to affect 1 in 58,000 individuals worldwide. Type 1 is the most common form, accounting for approximately 80 percent of cases. Types 2 and 3 each account for about 10 percent of cases.
Question: Is Werner syndrome inherited ?

Answer: Werner syndrome is inherited in an autosomal recessive pattern, which means both copies of the WRN gene in each cell have mutations. The parents of an individual with Werner syndrome each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.
Question: Is cap myopathy inherited ?

Answer: Cap myopathy is an autosomal dominant condition, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Most cases are not inherited; they result from new mutations in the gene and occur in people with no history of the disorder in their family.
Question: How many people are affected by rhizomelic chondrodysplasia punctata ?

Answer: Rhizomelic chondrodysplasia punctata affects fewer than 1 in 100,000 people worldwide. RCDP1 is more common than RCDP2 or RCDP3.
Question: What are the symptoms of Nephrotic Syndrome in Adults ?

Answer: In addition to proteinuria, hyperlipidemia, edema, and hypoalbumina, people with nephrotic syndrome may experience
                
- weight gain  - fatigue  - foamy urine  - loss of appetite
Question: What to do for What I need to know about Hepatitis A ?

Answer: If you have hepatitis A, you should do things to take care of yourself, including eating a healthy diet. Avoid drinking alcohol, which can harm the liver. Talk with your doctor before taking vitamins and other supplements.
Question: What are the treatments for Prostate Cancer ?

Answer: Surgery, radiation therapy, and hormonal therapy all have the potential to disrupt sexual desire or performance for a short while or permanently. Discuss your concerns with your health care provider. Several options are available to help you manage sexual problems related to prostate cancer treatment.
Question: What are the symptoms of Shingles ?

Answer: A week or two after the blisters erupt, the oozing sores will begin to crust over. The sores are usually gone after another two weeks. The pain usually decreases over the next few weeks, but some patients may have pain for months -- sometimes, for years.
Question: Do you have information about Asian American Health

Answer: Summary : Every racial or ethnic group has specific health concerns. Differences in the health of groups can result from       - Genetics    - Environmental factors    - Access to care    - Cultural factors        On this page, you'll find links to health issues that affect Asian Americans.
Question: Do you have information about African American Health

Answer: Summary : Every racial or ethnic group has specific health concerns. Differences in the health of groups can result from       - Genetics    - Environmental factors    - Access to care    - Cultural factors        On this page, you'll find links to health issues that affect African Americans.
Question: How to diagnose Lichen planus pigmentosus ?

Answer: How is lichen planus pigmentosus diagnosed? A diagnosis of lichen planus pigmentosus is usually suspected based on the presence of characteristic signs and symptoms. A skin biopsy may then be ordered to confirm the diagnosis.
Question: What causes Accessory navicular bone ?

Answer: What causes of accessory navicular bone? The cause of accessory navicular bone is unknown. In some cases, the condition may be related to the development of flatfoot also known as pes planus, in other cases it may be related to repeated foot and ankle sprains.
Question: What is (are) Parasites - Cyclosporiasis (Cyclospora Infection) ?

Answer: Cyclospora cayetanensis is a parasite composed of one cell, too small to be seen without a microscope. This parasite causes an intestinal infection called cyclosporiasis.
Question: what research (or clinical trials) is being done for Primary Lateral Sclerosis ?

Answer: The NINDS conducts a broad range of research on neuromuscular disorders such as PLS. This research is aimed at developing techniques to diagnose, treat, prevent, and ultimately cure these devastating diseases.
Question: What is the outlook for Coffin Lowry Syndrome ?

Answer: The prognosis for individuals with Coffin-Lowry syndrome varies depending on the severity of symptoms. Early intervention may improve the outlook for patients. Life span is reduced in some individuals with Coffin-Lowry syndrome.
Question: What is the outlook for Hemifacial Spasm ?

Answer: The prognosis for an individual with hemifacial spasm depends on the treatment and their response. Some individuals will become relatively free from symptoms with injection therapy. Some may require surgery. In most cases, a balance can be achieved, with tolerable residual symptoms.
Question: what research (or clinical trials) is being done for Cerebro-Oculo-Facio-Skeletal Syndrome (COFS) ?

Answer: The NINDS supports research on genetic disorders such as COFS. The goals of this research include finding ways to prevent, treat, and cure these disorders.
Question: What is the outlook for Tarlov Cysts ?

Answer: In some instances Tarlov cysts can cause nerve pain and other pain, weakness, or nerve root compression. Acute and chronic pain may require changes in lifestyle. If left untreated, nerve root compression can cause permanent neurological damage.
Question: How many people are affected by episodic ataxia ?

Answer: Episodic ataxia is uncommon, affecting less than 1 in 100,000 people. Only types 1 and 2 have been identified in more than one family, and type 2 is by far the most common form of the condition.
Question: Is genitopatellar syndrome inherited ?

Answer: This condition has an autosomal dominant inheritance pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. All reported cases have resulted from new mutations in the gene and have occurred in people with no history of the disorder in their family.
Question: How many people are affected by X-linked infantile spasm syndrome ?

Answer: Infantile spasms are estimated to affect 1 to 1.6 in 100,000 individuals. This estimate includes X-linked infantile spasm syndrome as well as infantile spasms that have other causes.
Question: How many people are affected by Kawasaki disease ?

Answer: In the United States and other Western countries, Kawasaki disease occurs in approximately 1 in 10,000 children under 5 each year. The condition is 10 to 20 times more common in East Asia, including Japan, Korea, and Taiwan.
Question: How many people are affected by neuropathy, ataxia, and retinitis pigmentosa ?

Answer: The prevalence of NARP is unknown. This disorder is probably less common than a similar but more severe condition, Leigh syndrome, which affects about 1 in 40,000 people.
Question: Is dermatofibrosarcoma protuberans inherited ?

Answer: Dermatofibrosarcoma protuberans results from a new mutation that occurs in the body's cells after conception and is found only in the tumor cells. This type of genetic change is called a somatic mutation and is generally not inherited.
Question: How many people are affected by Caffey disease ?

Answer: Caffey disease has been estimated to occur in approximately 3 per 1,000 infants worldwide. A few hundred cases have been described in the medical literature. Researchers believe this condition is probably underdiagnosed because it usually goes away by itself in early childhood.
Question: How many people are affected by mucolipidosis II alpha/beta ?

Answer: Mucolipidosis II alpha/beta is a rare disorder, although its exact prevalence is unknown. It is estimated to occur in about 1 in 100,000 to 400,000 individuals worldwide.
Question: How many people are affected by congenital cataracts, facial dysmorphism, and neuropathy ?

Answer: The prevalence of CCFDN is unknown. The disorder has been identified in about 150 individuals of Romani ethnicity. Thus far, no affected individuals have been observed outside this community.
Question: How many people are affected by Nijmegen breakage syndrome ?

Answer: The exact prevalence of Nijmegen breakage syndrome is unknown. This condition is estimated to affect one in 100,000 newborns worldwide, but is thought to be most common in the Slavic populations of Eastern Europe.
Question: Is Costello syndrome inherited ?

Answer: Costello syndrome is considered to be an autosomal dominant condition, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Almost all reported cases have resulted from new gene mutations and have occurred in people with no history of the disorder in their family.
Question: How many people are affected by glycogen storage disease type IX ?

Answer: GSD IX that affects the liver is estimated to occur in 1 in 100,000 people. The forms of the disease that affect muscles or both muscles and liver are much less common, although the prevalence is unknown.
Question: How many people are affected by medium-chain acyl-CoA dehydrogenase deficiency ?

Answer: In the United States, the estimated incidence of MCAD deficiency is 1 in 17,000 people. The condition is more common in people of northern European ancestry than in other ethnic groups.
Question: How many people are affected by myasthenia gravis ?

Answer: Myasthenia gravis affects about 20 per 100,000 people worldwide. The prevalence has been increasing in recent decades, which likely results from earlier diagnosis and better treatments leading to longer lifespans for affected individuals.